_20240814170432_original_image_40.webp)
Venkatraman's extensive career includes notable roles such as Senior Vice President of the API business at Shilpa Pharma Lifesciences, where he led the division to achieve significant revenue and EBITDA targets
Read More
The Government of India’s Amrit Kaal blueprint -Vision Pharma 2047 – which envisages India as ‘Vishwaguru’ (global leader) in innovation & research underscores the Government's commitment to nurture an innovation-driven ecosystem
Read More
The facility has been granted a Voluntary Action Indicated (VAI) status following an inspection that took place from May 7 to May 17, 2024
Read More
A study by business consultancy firm Grand View Research has estimated that the global pharma robotics market will expand at a CAGR of 8.7 per cent from 2023 to 2030 to reach USD 357.9 million by the end of this decade
Read More
